Ticker > Company >

Ind-Swift Labs. share price

Ind-Swift Laboratories Ltd.

  66.13 K   69   12 NSE: INDSWFTLAB BSE: 532305 SECTOR: Pharmaceuticals & Drugs

386.50
-27.15 (-6.56%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 424.55

Today's Low

₹ 376.1

52 Week High

₹ 419.45

52 Week Low

₹ 87

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 3361.06 Cr.

Enterprise Value

₹ 2963.77 Cr.

No. of Shares

8.7 Cr.

P/E

57.08

P/B

2.41

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  160.34

CASH

₹ 414.99 Cr.

DEBT

₹ 17.7 Cr.

Promoter Holding

42.93 %

EPS (TTM)

₹  6.77

Sales Growth

13.11%

ROE

3.46 %

ROCE

4%

Profit Growth

-83.38 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.11%
3 Year-17.97%
5 Year-5.78%

Profit Growth

1 Year-83.38%
3 Year0.07%
5 Year63.48%

ROE%

1 Year3.46%
3 Year29.37%
5 Year19.19%

ROCE %

1 Year4%
3 Year28.24%
5 Year20.97%

Debt/Equity

0.0129

Price to Cash Flow

-83.62

Interest Cover Ratio

36.7669

CFO/PAT (5 Yr. Avg.)

0.0712031785830365

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 42.93 0.00
Mar 2026 42.99 0.00
Dec 2025 39.50 0.00
Sep 2025 39.50 0.00
Jun 2025 40.94 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 11.588 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 36.7669.
  • The company has an efficient Cash Conversion Cycle of 0.222300000000018 days.
  • Company has a healthy liquidity position with current ratio of 3.4781.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 11.8972921605141.

 Limitations

  • The company has shown a poor profit growth of 0.0665094062148652% for the Past 3 years.
  • The company has shown a poor revenue growth of -17.9681600242067% for the Past 3 years.
  • Company has negative cash flow from operations of -40.1937.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 153.58 150.44 149.48 172.7 186.08
Total Expenditure 144.92 148.25 144.08 152.4 152.76
Operating Profit 8.66 2.19 5.4 20.31 33.32
Other Income 8.99 17.86 27.58 2.21 7.63
Interest 1.15 2.02 0.67 -2.44 0.71
Depreciation 6.68 6.98 8.84 8.08 7.58
Exceptional Items 0 0 -5.85 -5.15 -0.24
Profit Before Tax 9.83 11.06 17.62 11.72 32.43
Tax 1.71 2.3 6.87 -3.22 7.98
Profit After Tax 8.12 8.76 10.74 14.94 24.44
Adjusted EPS (Rs) 1.18 1.07 1.32 1.72 2.81

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 988.09 1151.96 1227.32 562.17 635.89
Total Expenditure 794.38 929.86 977.35 562.59 599.81
Operating Profit 193.71 222.09 249.97 -0.41 36.08
Other Income 42.5 33.28 45.31 68.75 57.11
Interest 95.55 92.17 51.1 2.92 1.4
Depreciation 130.97 57.36 53.3 24.48 30.57
Exceptional Items -1.69 -26.65 386.59 223.2 -11.01
Profit Before Tax 8 79.2 577.47 264.14 50.22
Tax 13.7 36.73 159.08 8.06 7.66
Net Profit -5.71 42.47 418.39 256.09 42.56
Adjusted EPS (Rs.) -0.97 7.19 70.81 37.25 4.9

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 59.81 59.81 59.09 68.74 86.84
Total Reserves 572.75 615.54 863.16 1095.33 1283.86
Borrowings 839.07 744.43 3 22.54 12.11
Other N/C liabilities -32.7 -11.41 -30.61 -25.55 -30.35
Current liabilities 313.61 350.05 178.32 216.35 251.55
Total Liabilities 1752.53 1758.42 1072.95 1377.42 1604
Assets
Net Block 626.79 585 5.32 270.72 301.57
Capital WIP 9.31 7.71 0 0 10.2
Intangible WIP 1 0 0 0 2.21
Investments 110.68 85.12 165.94 229.55 318.55
Loans & Advances 3.89 4.1 353.84 81.17 94.37
Other N/C Assets 4.72 3.82 2.3 2.25 2.21
Current Assets 996.15 1072.67 545.54 793.73 874.91
Total Assets 1752.53 1758.42 1072.95 1377.42 1604
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 9.69 105.85 190.88 40.94 61.22
Adjustment 225.59 132.78 124.76 -36.92 -19.93
Changes in Assets & Liabilities -99.02 -55.95 -495.41 -42.75 -74.79
Tax Paid 0 0 0 -6.57 -6.7
Operating Cash Flow 136.26 182.67 -179.77 -45.3 -40.19
Investing Cash Flow 2.76 -13.69 -104.32 -109.67 -100.16
Financing Cash Flow -139.59 -168.41 699.86 77.44 145.26
Net Cash Flow -0.57 0.58 415.77 -77.53 4.9

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE
Credit CARE
Credit ICRA
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q3FY26
Presentation Q2FY21
Presentation Q1FY27

Company News

Ind-Swift Labs. Stock Price Analysis and Quick Research Report. Is Ind-Swift Labs. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Ind-Swift Labs.. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Ind-Swift Labs. has a PE ratio of 61.0101905183872 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Ind-Swift Labs. has ROA of 2.8548% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Ind-Swift Labs. has a Current ratio of 3.4781.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Ind-Swift Labs. has a ROE of 3.4602%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Ind-Swift Labs. has a Debt to Equity ratio of 0.0129 which means that the company has low proportion of debt in its capital.

  • Sales growth: Ind-Swift Labs. has reported revenue growth of 13.1125% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Ind-Swift Labs. for the current financial year is 5.67420231691562%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Ind-Swift Labs. is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Ind-Swift Labs. is Rs 6.771. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Ind-Swift Labs. in Ticker for free. Also, one can get the intrinsic value of Ind-Swift Labs. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Ind-Swift Labs. FAQs

Q1. What is Ind-Swift Labs. share price today?
Ans: The current share price of Ind-Swift Labs. is Rs 413.1.

Q2. What is the market capitalisation of Ind-Swift Labs.?
Ans: Ind-Swift Labs. has a market capitalisation of Rs 3592.38196098 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Ind-Swift Labs.?
Ans: The PE ratio of Ind-Swift Labs. is 61.0101905183872 and the P/B ratio of Ind-Swift Labs. is 2.57640014968193, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Ind-Swift Labs. share?
Ans: The 52-week high share price of Ind-Swift Labs. is Rs 419.8, and the 52-week low share price of Ind-Swift Labs. is Rs 87.15.

Q5. Does Ind-Swift Labs. pay dividends?
Ans: Currently, Ind-Swift Labs. does not pay dividends. Dividend yield of Ind-Swift Labs. is around 0%.

Q6. What are the face value and book value of Ind-Swift Labs. shares?
Ans: The face value of Ind-Swift Labs. shares is Rs 10, while the book value per share of Ind-Swift Labs. is around Rs 160.34. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Ind-Swift Labs.?
Ans: Ind-Swift Labs. has a total debt of Rs 17.7015 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Ind-Swift Labs.?
Ans: The ROE of Ind-Swift Labs. is 3.4602% and ROCE of Ind-Swift Labs. is 3.9989%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Ind-Swift Labs. a good buy for the long term?
Ans: The Ind-Swift Labs. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Ind-Swift Labs. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Ind-Swift Labs. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Ind-Swift Labs.’s financials?
Ans: You can review Ind-Swift Labs.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Ind-Swift Labs.
X